Objective: We investigated contribution of TNF-a-dependent and TNF-a-independent signals to the development of dermatitis in epidermis-specific Cflar-deficient (Cflar 
;Tnfrsf1a
2/2 mice still died of apoptosis, neutralizing antibodies against Fas ligand and TNF-related apoptosisinducing ligand substantially prolonged survival of Cflar E-KO ; Tnfrsf1a 2/2 mice. Expression of inflammatory cytokines, such as Il6 and Il17a was increased; conversely, expression of epidermal differentiation markers was severely downregulated in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice. Treatment of primary keratinocytes with IL-6 and, to a lesser extent, IL-17A suppressed expression of epidermal differentiation markers. Conclusion: TNF receptor superfamily 1 (TNFR1)-dependent or TNFR1-independent apoptosis of keratinocytes promotes inflammatory cytokine production, which subsequently blocks epidermal differentiation. Thus blockade of both TNFR1-dependent and TNFR1-independent cell death might be an alternative strategy to treat skin diseases when treatment with anti-TNF-a antibody alone is not sufficient. (J Allergy Clin Immunol 2019;143:213-28.)
Key words: Cellular FLICE-inhibitory protein, apoptosis, epidermal differentiation, TNF-a Skin homeostasis is maintained through a delicate balance between proliferation and differentiation of keratinocytes that constitutes the first line defense against microbes or various environmental stresses.
1,2 Keratinocyte cell death is tightly regulated to maintain tissue homeostasis; however, the detailed molecular mechanism is not fully understood.
Psoriasis is a chronic human skin disease characterized by hyperproliferation of epidermal cells, parakeratosis, and massive T-cell infiltration. 3, 4 Various murine models have been established to understand the mechanisms underlying psoriasis. Accumulating studies with epidermis-specific nuclear factor kB (NF-kB) activation-deficient mice reported that mice have psoriasis-like dermatitis along with an increase in apoptosis of keratinocytes and upregulation of inflammatory cytokines. [5] [6] [7] [8] [9] [10] [11] Importantly, the phenotypes of epidermis-specific NF-kB activation-deficient mice are attenuated when mice are crossed with Tnfrsf1a 2/2 mice or treated with neutralizing antibody against TNF-a. [5] [6] [7] [8] [9] [10] [11] Those studies combined with others have shown that TNF-a, T H 17 cells, and T H 17 signature cytokines, such as IL-17A, IL-22, and IL-23, are involved in the development of murine models of psoriasis. 12, 13 Consistently, anti-TNF-a and anti-IL-17A antibodies are used to treat psoriasis. 3, 4 Although expression of IL-6 is increased in the skin of patients with psoriasis and murine skin disease models, as described above, blockade of IL-6 function exacerbates disease severity in both human subjects and mice. 14, 15 Blockade of apoptosis through deletion of caspase 8 or Fadd in murine epidermis culminates in the development of dermatitis. 16, 17 Deletion of receptor-interacting protein kinase 3 (RIPK3), an essential kinase for programmed necrosis or necroptosis, blocks the development of dermatitis in epidermis-specific caspase 8-or Fadd-deficient mice. 16, 17 This suggests that the apoptotic signaling pathway blocks RIPK3-dependent necroptosis under normal conditions. Intriguingly, the skin phenotypes of epidermis-specific NF-kB activation-deficient or apoptosisdeficient mice are very similar, and all mice exhibit hyperproliferation of basal cells, persistent presence of undigested nuclei in cornified cells (parakeratosis), and impaired differentiation of epidermal cells along with an increase in cell death. 18 These results suggest that dying keratinocytes can release growth factors, thereby inducing proliferation and aberrant differentiation of keratinocytes. One of the candidates that links cell death and proliferation might be IL-24 because deletion of a receptor for IL-24 abrogates dermatitis in epidermis-specific Ikkb-deficient mice. 7 However, the detailed molecular signatures are not fully elucidated.
Accumulating studies, including by us, have reported that cellular FLICE (FADD-like ICE)-inhibitory protein (cFLIP) plays a crucial role in maintaining tissue homeostasis by preventing apoptosis and programmed necrosis. [19] [20] [21] [22] [23] [24] Moreover, previous studies have shown that inducible deletion of the Cflar gene that encodes cFLIP in the epidermis results in severe dermatitis that is blocked by neutralization of TNF-a-mediated cytotoxicity. 25, 26 Taken that cFLIP plays an essential role in protection of cell death induced by Fas ligand (FasL) and TNFrelated apoptosis-inducing ligand (TRAIL), 27, 28 it is unclear whether TNF-a-independent signal also induces dermatitis in epidermis-specific Cflar-deficient mice.
In the present study we generated epidermis-specific Cflardeficient (Cflar E-KO ) mice. We found that TNF receptor superfamily 1 (TNFR1)-dependent signal induced massive apoptosis of keratinocytes in utero, resulting in embryonic lethality of Cflar E-KO mice. Although Tnfrsf1a deficiency rescued embryonic lethality of Cflar E-KO mice, Cflar E-KO ;Tnfrsf1a 2/2 mice still had dermatitis and succumbed soon after birth. Notably, keratinocytes still died through apoptosis in the skin of Cflar E-KO ;Tnfrsf1a . cFLIP blocks TNFR1-dependent and TNFR1-independent apoptosis of keratinocytes, thereby preventing a defect in epidermal differentiation. Thus blockade of TNFR1-dependent and TNFR1-independent apoptosis is crucial for normal epidermal differentiation, thereby blocking dermatitis.
METHODS Reagents
Murine IL-6 (406-ML; R&D Systems, Minneapolis, Minn), IL-17A (210-17; PeproTech, Rocky Hill, NJ), IL-24 (7807-ML; R&D Systems), and IFNg (315-05; PeproTech) and murine and human TNF-a (34-8321 and BMS301; eBioscience, San Diego, Calif), z-VAD-fmk (3188-v; Peptide, Osaka, Japan), and Necrostatin-1 (N9037; Sigma-Aldrich, St Louis, Mo) were purchased from the indicated sources. The following antibodies were used in this study and obtained from the indicated sources: anti-Lor (PRB-145P; Covance, Cincinnati, Ohio), anti-Flg (PRB-417P; Covance), anti-Krt5 (PRB-160P; Covance), anti-Krt10 (RPB-159P; Covance), anti-cFLIP (804-127; Alexis, San Diego, Calif), anti-tubulin (T5168; Sigma-Aldrich), antiphospho-signal transducer and activator of transcription (STAT) 1 (8826; Cell Signaling, Danvers, Mass), anti-STAT1 (9172; Cell Signaling), antiphospho-STAT3 (9145S; Cell Signaling), anti-STAT3 (sc-482; Santa Cruz Biotechnology, Dallas, Tex), anti-phospho-IkBa (2859; Cell Signaling), anti-cleaved caspase 3 (CC3; 9664; Cell Signaling), anti-caspase 8 (804-447; Alexis), anti-CD11b (M1/70; TONBO Biosciences, San Diego, Calif), anti-CD3 (ab5690; Abcam, Cambridge, United Kingdom), anti-F4/80 (MCA497GA; Bio-Rad Laboratories, Hercules, Calif), anti-Fas (SY-001; MBL, Nagoya, Japan), anti-Ly-6G (1A8; TONBO), anti-RIPK1 (R41220; BD Bioscience, San Jose, Calif), anti-RIPK3 (IMG-5523-2; IMGENEX, San Diego, Calif), anti-Ki67 (Ab16667; Abcam), anti-IL-6 (MP5-20F3; Bio X Cell, West Lebanon, NH), and anti-FLAG (M2; Sigma-Aldrich) antibodies and control rat IgG (14131; Sigma-Aldrich). Anti-mixed lineage kinase domain-like protein (MLKL) antibody was provided by J. Murphy and J. Silke. Anti-FasL (MFL4) and anti-TRAIL (N2B2) antibodies for in vivo administration were made in-house. Alexa Fluor 594-conjugated donkey anti-rabbit IgG (A21207; Invitrogen, Carlsbad, Calif), Alexa Fluor 488-conjugated donkey anti-rabbit IgG (A21206; Invitrogen), Alexa Fluor 488-conjugated goat anti-rabbit (A11070; Invitrogen), Alexa Fluor 488-conjugated donkey anti-rat IgG (A21209; Invitrogen), horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG (NA934; GE Healthcare, Fairfield, Conn), HRP-conjugated goat anti-rat IgG (NA935; GE Healthcare), HRPconjugated sheep anti-mouse IgG (NA931; GE Healthcare) antibodies, biotin-conjugated goat anti-rabbit IgGs (E0432; Dako, Glostrup, Denmark), and streptavidin-HRP (P0397; Dako) were also used.
Cells
HaCaT cells, a human keratinocyte cell line; HeLa cells, a human cell line derived from cervical carcinoma; and RAW264.7 cells, a murine macrophage cell line, were maintained with Dulbecco modified Eagle medium containing 10% FCS. 
Mice

Measurement of transepidermal water loss
Seven-day-old mice were subjected to transepidermal water loss (TEWL) analysis. TEWL was measured with a Vapometer (Delfin Technologies, Kuopio, Finland).
Preparation of primary keratinocytes
Keratinocyte preparation was described elsewhere, with minor modifications. 31 Briefly, the skin of mice at P0 was removed and immersed in a lowcalcium medium, CnT-PR (CELLnTEC, Berne, Belgium), containing Dispase I (1000 PU/mL; 386-02271; WAKO, Richmond, Va) at 48C overnight. The epidermis was peeled off from the dermis with forceps and chopped into small pieces. Then minced tissues were incubated with Accutase (AT104; Innovative Cell Technologies, San Diego, Calif) at room temperature for 10 minutes and filtrated with nylon mesh. Cells were washed with CnT-PR several times and cultured in the same medium.
Culture medium was changed to CnT-PR-D medium (CELLnTEC) to induce keratinocyte differentiation. Once cells became confluent, they were cultured further in the absence or presence of TNF-a, IL-6, IL-17A, or IL-24 for 96 hours.
WST (water-soluble tetrazolium salt) assay
Primary keratinocytes (2 3 10 4 cells) were plated on 96-well plates and then stimulated with the indicated concentrations of TNF-a, recombinant leucine zipper FasL (Alexis), or Flag-tagged TRAIL that had been crosslinked with anti-Flag antibody. Flag-tagged TRAIL was provided by T. Noguchi, as previously described. 32 After 18 hours, cell viability was determined by using the WST assay (Cell Counting Kit-8; Dojindo, Kumamoto, Japan).
HaCaT cells were transfected with control small interfering RNA (siRNA; 12935112; Thermo Fisher Scientific, Waltham, Mass) or siRNAs targeted against human CFLAR (Qiagen, Hilden, Germany) by using Lipofectamine 2000 (Invitrogen). Target sequences were as follows: CFLAR #1, 59-AAG GAGCAGGGACAAGUUACAdTdT-39; CFLAR #2, 59-AAGCAAGGA GAAGAGUUUCUUdTdT-39. Twenty-four hours later, cells (1.5 3 10 4 ) were plated on 96-well plates and stimulated with the indicated concentrations of anti-Fas antibody, Flag-tagged TRAIL, or human TNF-a. Cell viability was determined by using the WST assay. Knockdown of cFLIP in HaCaT cells was verified by means of Western blotting with anti-cFLIP antibody.
Western blotting
The skin was homogenized with a Polytron (KINEMATICA, Bohemia, NY) or cells were lysed in RIPA buffer (50 mmol/L Tris-HCl [pH 8.0], 150 mmol/L NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 25 mmol/L b-glycerophosphate, 1 mmol/L sodium orthovanadate, 1 mmol/ L sodium fluoride, 1 mmol/L phenylmethylsulfonyl fluoride, 1 mg/mL aprotinin, and 1 mg/mL leupeptin). After centrifugation, skin extracts or cell lysates were subjected to SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Millipore, Burlington, Mass). The membranes were analyzed by means of immunoblotting with the indicated antibodies. Membranes were developed with Super Signal West Dura Extended Duration Substrate (Thermo Scientific) and analyzed with an Amersham Imager 600 (GE Healthcare).
Histologic, immunohistochemical, and immunofluorescence analyses
The skin was fixed in 10% formalin and embedded in paraffin blocks. Paraffin-embedded skin sections were used for hematoxylin and eosin staining or stained with the indicated antibodies and then visualized with HRPconjugated streptavidin and diaminobenzidine (for anti-CC3 and anti-Ki67 antibodies). Numbers of CC3 1 or Ki67 1 cells were counted in 3 randomly selected fields and expressed as average numbers per square millimeter of skin for each mouse. Epidermal thickness was evaluated by measuring epidermal thickness from the basal layer to the stratum corneum, as described elsewhere. 33 The thickness was calculated on 10 randomly selected areas from 3 fields and averaged per mouse. Pictures were obtained with an Olympus BX63 and analyzed by cellSens imaging software (Olympus, Center Valley, Pa).
Paraffin-embedded skin sections were stained with anti-phospho-STAT3 antibody and their signals were enhanced by using Tyramide signal amplification Plus Fluorescence Systems (NEL741001KT; PerkinElmer, Waltham, Mass), according to the manufacturer's instructions to detect phosphorylated STAT3. Paraffin-embedded skin sections were stained with anti-Lor, anti-Krt10, or antiKrt5 antibodies and visualized with Alexa Fluor 594-conjugated donkey anti-rabbit immunoglobulin antibody. Frozen skin sections were incubated with anti-CD3, anti-CD11b, anti-F4/80, or anti-Ly-6G antibodies and visualized with Alexa Fluor 488-conjugated donkey anti-rat IgG antibody. Pictures were obtained with an All-In-One Microscope (BZ-X700; KEYENCE, Osaka, Japan) or Nikon A1 confocal microscope (Nikon, Tokyo, Japan).
Histologic analysis of human skin samples
Skin samples were collected from patients with Stevens-Johnson syndrome (n 5 2), atopic dermatitis with chronic lesions (n 5 3), and psoriasis (n 5 3) after obtaining informed consent. Paraffin-embedded skin sections were stained with hematoxylin and eosin. Frozen skin sections were stained with anti-CC3 antibody, followed by Alexa Fluor 488-conjugated goat anti-rabbit antibody. The study was approved by the Ethics Committee of Niigata University Graduate School of Medical and Dental Sciences.
Transmission electron microscopy
Skin sections were fixed with 2% glutaraldehyde in 0.1 mol/L phosphate buffer, pH 7.4. Slices of these fixed tissues were postfixed with 2% OsO 4 , dehydrated in ethanol, and embedded in Epok 812 (Oken Shoji, Tokyo, Japan). Ultrathin sections were cut with an ultramicrotome (ultracut N or UC6; Leica, Wetzlar, Germany) and stained with uranyl acetate and lead citrate and then were examined on a Hitachi HT7700 (Hitachi, Tokyo, Japan) or JEOL JEM-1400 electron microscope (JEOL, Peabody, Mass).
Microarray analysis
We compared gene expression profiles of RNAs from Cflar and Cflar E-KO ;Tnfrsf1a 1/2 mice at E18.5 (embryonic or postcoital 18.5). The experiments were performed with 2 mice per genotype. Total RNA was extracted from the skin of mice of the indicated genotype by using TRIzol (Molecular Research Center, Cincinnati, Ohio), according to the manufacturer's instructions, and then labeled with Cy3. Samples were hybridized to a Mouse Oligonucleotide Microarray (G4121B; Affymetrix, Santa Clara, Calif), according to the manufacturer's protocol. Arrays were scanned with a G2565BA Microarray Scanner System (Affymetrix). Data were analyzed with GeneSpring GX software (Agilent Technologies, Santa Clara, Calif) and deposited with the National Center for Biotechnology Information as GEO accession number GSE99379.
Quantitative PCR
Total RNAs from the skin of indicated genotypes of mice were extracted, and cDNAs were synthesized with ReverTra Ace (TOYOBO, Osaka, Japan). Quantitative PCR analysis was performed with the 7500 Real-Time PCR detection system with SYBR green method of the target genes together with an endogenous control, murine Hprt with 7500 SDS software (Applied Biosystems, Foster City, Calif). Primer sequences used in this study are listed in Table E1 in this article's Online Repository at www.jacionline.org. Gene amount were expressed relative to those of murine Hprt with 7500 SDS software (Applied Biosystems).
In vivo antibody administration
Mice were injected intradermally with both anti-FasL and anti-TRAIL antibodies (25 mg of each antibody per mouse), anti-IL-6 antibody, or control rat IgG (50 mg per mouse) at P3, and injection was continued every other day until the pups died. Mice were killed at P6, and skin sections were examined to evaluate the therapeutic effects of administered antibodies.
Statistical analysis
Statistical analysis was performed with the unpaired Student t test, Tukey 1-way ANOVA, or the log-rank test, as appropriate. A P value of less than .05 was considered statistically significant.
RESULTS
Epidermis-specific Cflar-deficient mice on the Tnfrsf1a 2/2 background are born at the expected Mendelian ratio but have lethal dermatitis
Although epidermis-specific Cflar-deficient mice die in utero, 26 inducible deletion of Cflar in the epidermis results in severe dermatitis that is blocked by neutralizing antibody against TNF-a. 25, 26 To investigate whether the TNFR1-independent signal can contribute to development of dermatitis in epidermisspecific Cflar-deficient (Cflar E-KO ) mice, we crossed Cflar flox/ flox mice with Krt5-Cre recombinase mice on the Tnfrsf1a 2/2 genetic background. Cflar E-KO ;Tnfrsf1a 2/2 mice were born at the expected Mendelian ratios (see Table E2 in this article's Online Repository at www.jacionline.org). Cflar E-KO ;Tnfrsf1a 2/2 mice appeared to be normal at birth (Fig 1, A) but gradually had dermatitis characterized by enhanced cornification on the dorsal side of the skin at postnatal days 5 to 7 (P5-P7; Fig 1, B) . Ectopic cornification of the epidermis might impair barrier function of the skin, resulting in an increase in water loss. 34 Indeed, TEWL was significantly increased in the epidermis in Cflar E-KO ;Tnfrsf1a 2/2 mice compared with that in Tnfrsf1a 2/2 mice at P7 (Fig 1, C) . Histologic analysis revealed that some basal cells in the epidermis in Cflar E-KO ;Tnfrsf1a 2/2 mice were already irregularly arranged at birth (Fig 1, D) . The epidermis in Cflar E-KO ; Tnfrsf1a 2/2 mice became thickened because of enhanced cornification along with parakeratosis at P5 to P7 (Fig 1, D) . Although CC3 1 cells were hardly detected in the epidermis of both genotyped mice at P0, numbers of CC3 1 cells were increased significantly in the epidermis in Cflar E-KO ;Tnfrsf1a 2/2 mice compared with that in Tnfrsf1a 2/2 mice at P5 to P7, suggesting that these cells died of apoptosis (Fig 1, E) . Intriguingly, numbers of proliferating basal cells were also increased in Cflar E-KO ; Tnfrsf1a 2/2 mice compared with control mice at P5 to P7 (Fig  1, F) . These results suggest that Cflar E-KO ;Tnfrsf1a 2/2 mice had severe dermatitis soon after birth in a TNFR1-independent manner.
Susceptibility to FasL-and TRAIL-induced cell death is increased in primary keratinocytes from Cflar E-KO ; Tnfrsf1a 2/2 mice
To investigate the cause of apoptosis of keratinocytes in Cflar E-KO ;Tnfrsf1a 2/2 mice, we first compared expression of cell death-regulating proteins. Expression of caspase 8 and (Fig 1, A) and P5 (Fig 1, B ; n 5 20 mice per each genotype). White arrowheads indicate areas showing desquamation. C, Significant increase in TEWL in 7-dayold Cflar E-KO ;Tnfrsf1a 2/2 mice. Results are means 6 SEMs (n 5 6 mice per each genotype). D, Hematoxylin and eosin-stained skin sections (n 5 10 mice per each genotype) at P0 (left) and P5 to P7 (right). Red and white arrowheads indicate irregularly arranged basal cells and pyknotic nuclei, respectively. Scale bars 5 100 mm. E and F, CC3 1 (Fig 1, E) or Ki67 1 (Fig 1, F) cells in the skin of mice at P0 and P5 to P7 (brown; n 5 4 mice per each genotype). Red arrowheads indicate CC3 1 cells. Nuclei were stained with hematoxylin.
Numbers of CC3
1 or Ki-67 1 cells were counted and are expressed as numbers per square millimeter in the skin of mice. Results are means 6 SEMs (n 5 4 mice per each genotype). **P < .01 and ***P < .001. ns, Not significant. Scale bars 5 100 mm.
J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 1 RIPK1 in the skin was not altered between Cflar E-KO ;Tnfsfr1a
and Tnfrsf1a 2/2 mice at P0 or P6. RIPK3 expression was increased slightly in the skin of Cflar E-KO ;Tnfsfr1a 2/2 compared with Tnfrsf1a 2/2 mice at P5 to P7 but not P0. Moreover, MLKL protein, an effector molecule of necroptosis, was undetectable in the skin of either type of genotyped mice at P0, whereas MLKL was increased in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7 (Fig 2, A) . Although the mechanism underlying an increase in RIPK3 and MLKL expression is currently unknown, increased RIPK3 and MLKL expression might increase susceptibility to necroptosis.
We next prepared primary keratinocytes from Cflar E-KO ; Tnfrsf1a 2/2 mice at P0. We first confirmed that expression of cFLIP L was abolished in primary keratinocytes from Cflar E-KO ; Tnfrsf1a 2/2 mice (Fig 2, B) . Although TNF-a induces cell death through TNFR2, as well as TNFR1, in certain types of cells, 35 TNF-a did not induce cell death of keratinocytes from Cflar E-KO ;Tnfrsf1a 2/2 mice (Fig 2, B) . This suggests that
An increase in susceptibility to FasL-and TRAIL-induced apoptosis of Cflar-deficient keratinocytes. A, Extracts from skin of mice at P0 and P5 to P7 were analyzed by using immunoblotting. Each number indicates an individual mouse (n 5 4 mice per each genotype). B, Lysates of primary keratinocytes from mice were analyzed by using immunoblotting. Primary keratinocytes were stimulated, and cell viability was determined by using the WST assay. Results are means 6 SDs of triplicate samples. C, Primary keratinocytes were stimulated as in Fig 2, B, in the absence or presence of z-VAD-fmk (50 mmol/L), Necrostatin-1 (Nec-1; 20 mmol/L), or z-VAD-fmk plus Nec-1. Cell viability was determined by using the WST assay. Results are means 6 SDs of triplicate samples. D, HaCaT cells treated with the indicated siRNAs were stimulated with the indicated concentrations of TNF-a, anti-Fas antibody, or TRAIL. Cell viability was determined by using the WST assay. Results are means 6 SDs of triplicate samples. E, mRNA expression of indicated genes of the skin was determined by using quantitative PCR. Results are means 6 SEs (n 5 4 to 10 mice per each genotype). Results are representative of 2 independent experiments (Fig 2, A-D ). *P < .05, **P < .01, and ***P < .001. ns, Not significant.
TNFR2-dependent cell death was not responsible for TNFR1-independent cell death under these experimental conditions. Because we reported previously that TNF-a-, FasL-, and TRAIL-induced liver injury is dramatically enhanced in Cflar F/F ; Mx1-Cre mice after polyinosinic-polycytidylic acid injection, 22 we next treated primary keratinocytes with these death ligands. FasL-and TRAIL-induced cytotoxicity were significantly increased in primary keratinocytes from Cflar E-KO ;Tnfrsf1a
mice compared with those from control mice (Fig 2, B) . Cell viability was increased significantly in the presence of a broad caspase inhibitor, z-VAD-fmk, and then further increased to control levels in the presence of both z-VAD-fmk and a RIPK1 inhibitor, Necrostatin-1 (Fig 2, C) . These results suggest that FasL and TRAIL might contribute to TNFR1-independent apoptosis and necroptosis of keratinocytes from Cfar E-KO ; Tnfrsf1a 2/2 mice. We also observed that TNF-a-, Fas-, and TRAIL-induced cell death was increased in human keratinocytes treated with CFLAR White arrowheads indicate small foci of Ly-6G 1 neutrophils. **P < .01 and ***P < .001. ns, Not significant. Scale bars 5 100 mm.
siRNAs compared to control siRNA (Fig 2, D) . Consistently, numbers of CC3 1 cells were detected in patients with StevensJohnson syndrome, a rare skin disease caused by drugs or viral infection (see Fig E1 in this article' s Online Repository at www.jacionline.org). 36 However, as far as we examined, CC3
1 cells were not detected in the skin in the setting of atopic dermatitis with chronic lesions or psoriasis (see Fig E1) . Although expression of Tnfsf6, which encodes FasL, was not different in between the skin of Cflar E-KO ;Tnfrsf1a 2/2 and Tnfrsf1a 2/2 mice at P0, its expression was significantly increased in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7 (Fig 2, E) . On the other hand, expression of Tnfsf10, which encodes TRAIL, was not different between the skin of Cflar E-KO ;Tnfrsf1a 2/2 and Tnfrsf1a 2/2 mice at P0 or P5 to P7 (Fig 2, E) . Thus it is plausible that these death ligands might induce cell death of keratinocytes in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice in vivo.
Blockade of FasL and TRAIL signals ameliorates dermatitis and prolongs survival of Cflar E-KO ; Tnfrsf1a 2/2 mice To test the possibility described above, we injected neutralizing antibodies against both FasL and TRAIL (hereafter known as anti-FT antibodies) into Cflar E-KO ;Tnfrsf1a 2/2 mice at P3 and then continued injection every other day until the pups died. Treatment of Cflar E-KO ;Tnfrsf1a 2/2 mice with anti-FT antibodies substantially prolonged their survival compared with that of control IgG-treated Cflar E-KO ;Tnfrsf1a 2/2 mice (Fig 3, A) . Thus FasL-and TRAIL-dependent cell death contributed, at least in part, to the development of TNFR1-independent lethal dermatitis.
To further investigate the mechanism by which blockade of FasL and TRAIL signals attenuated dermatitis, we examined histology of the skin of control IgG-or anti-FT antibody-treated Cflar E-KO ;Tnfrsf1a 2/2 mice. The epidermis was thickened, and numbers of CC3 1 cells were increased in control IgG-treated Cflar E-KO ;Tnfrsf1a 2/2 mice compared with control IgG-treated Tnfrsf1a 2/2 mice. Such skin phenotypes were attenuated significantly in anti-FT antibody-treated Cflar E-KO ;Tnfrsf1a 2/2 mice (Fig 3, B) .
We next examined infiltrated immune cells in the skin using immunohistochemistry. Few F4/80 1 cells resided in the skin of both types of genotyped mice at P0 (Fig 3, C) (Fig 3,  C) . Administration of anti-FT antibodies, but not control IgG, attenuated infiltration of CD11b 1 and F4/80 1 cells in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice (Fig 3, D) . Moreover, some foci containing Ly-6G 1 neutrophils were detected in the skin of control IgG-treated but not anti-FT antibody-treated Cflar E-KO ; Tnfrsf1a 2/2 mice (Fig 3, D) . Given that infiltrated CD11b 1 and F4/80 1 cells are considered to be bone marrow-derived inflammatory monocytes or dendritic cells, 33 these cells might contribute to the exacerbation of dermatitis of Cflar E-KO ; Tnfrsf1a 2/2 mice. In sharp contrast to skin disease models of adult mice or human psoriasis, 2-4 contribution of CD3 1 T cells to the development of dermatitis appears to be marginal in our skin disease model of neonatal mice.
Notably, the effect of anti-FT antibodies on survival of Cflar E-KO ;Tnfrsf1a 2/2 mice was partial, and anti-FT antibodytreated Cflar E-KO ;Tnfrsf1a 2/2 mice gradually had severe dermatitis and eventually died at around P10 (Fig 3, A) .
These results suggest that the other cell death pathway might also contribute to the development of TNFR1-independent lethal dermatitis. Indeed, several studies have shown that keratinocytes undergo pyroptosis. 37, 38 Notably, expression of a component of the inflammasome, Nlrp3, but not Nlrc4 or Naip1, was significantly increased in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice
Epidermal differentiation is blocked in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice. A, Skin sections of mice at P0 and P5 to P7 were stained with the indicated antibodies (red; n 5 4 mice per each genotype). Nuclei were stained with 49-6-diamidino-2-phenylindole dihydrochloride (DAPI). Scale bars 5 100 mm. B, Extracts from the skin of mice at P0 and P5 to P7 were analyzed by using immunoblotting. Each number indicates an individual mouse. Results are representative of 2 independent experiments (n 5 4 mice per each genotype). C, mRNA expression of indicated genes of the skin of mice was determined by using quantitative PCR. Results are means 6 SEs (n 5 4 mice per each genotype). *P < .05, **P < .01, and ***P < .001. ns, Not significant.
J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 1 compared with that of Tnfrsf1a 2/2 mice at P5 to P7 (see Fig E2 in this article's Online Repository at www.jacionline.org). These results suggest that inflammasome-dependent pyroptosis can also contribute to TNFR1-independent cell death.
Keratinocytes die because of apoptosis in the epidermis of Cflar E-KO ;Tnfrsf1a 2/2 mice
To investigate the morphology of dying keratinocytes in more detail, we examined the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice using transmission electron microscopy. We found that a few keratinocytes in the epidermis of Cflar E-KO ;Tnfrsf1a 2/2 mice exhibited chromatin condensation at P4, but not P1, further substantiating that keratinocytes died from apoptosis (Fig 4, A) . Cohesion between keratinocytes in the epidermis of Cflar E-KO ;Tnfrsf1a 2/2 mice was impaired at P1 and persisted at P4, which was a typical feature of spongiosis (Fig 4, B) . Moreover, the basal lamina of the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice was partially disrupted at P4 but appeared normal at P1 (Fig 4, C) . Intriguingly, small electrondense materials accumulated in mitochondria at P1 and gradually B and C, Hematoxylin and eosin-stained skin sections (n 5 4 mice per each genotype) at E14.5 (Fig 6, B) and E18.5 (Fig 6, C) . Scale bars 5 100 mm. D, Skin sections were stained with anti-CC3 antibody (brown; n 5 4 mice per each genotype). Nuclei were stained with hematoxylin. Scale bars 5 100 mm. E, mRNA expression of indicated genes of the skin of mice at E18.5 was determined by using quantitative PCR. Results are means 6 SEs (n 5 4-6 mice per each genotype). *P < .05. ns, Not significant. F, Skin sections at E18.5 were stained with anti-Ki67 (brown; n 5 4 mice per each genotype). Red arrowheads and arrows indicate Ki67 1 (proliferating) basal cells and disappearance of Ki67 1 basal cells, respectively. Nuclei were stained with hematoxylin. Scale bars 5 100 mm.
increased in size, culminating in a fully occupied matrix of mitochondria at P4 (Fig 4, D) . Taken that the electron-dense materials appeared to be lipids, the metabolism of lipids in mitochondria might be impaired in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice. Alterations in morphology of keratinocytes in the epidermis of Cflar E-KO ;Tnfrsf1a 2/2 mice already started at P1 and worsened progressively soon after birth.
Expression of epidermal differentiation markers, including Lor, Flg, and Krt10, are diminished in the epidermis in Cflar E-KO ;Tnfrsf1a 2/2 mice
To test whether an increase in apoptosis might impair epidermal differentiation, we examined expression of epidermal differentiation markers, including Lor, Krt10, and Krt5, using immunohistochemistry. These markers were expressed in the epidermis in Cflar E-KO ;Tnfrsf1a 2/2 mice comparable with that seen in Tnfrsf1a 2/2 mice at P0 (Fig 5, A) . In sharp contrast, expression of Lor and Krt10, but not Krt5, completely disappeared in the epidermis in Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7. Western blotting analysis verified that expression of Lor and Krt10, but not Krt5, in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7, but not P0, disappeared completely (Fig 5, B) . Flg is produced as a proform with approximately 400 kDa and processed into a mature form along with the development of mice. 39 Although a mature form of Flg was not detected in the skin of both Tnfrsf1a 2/2 mice and Cflar E-KO ;Tnfrsf1a 2/2 mice at P0, the processed form was detected in the skin of Tnfrsf1a 2/2 mice at P5 to P7. In sharp contrast, a processed form of Flg was not detected in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7 (Fig 5, B) . Although mRNA expression of Lor, Krt10, and Krt5, but not Flg, was not different in the skin between these mice at P0 (Fig 5, C) , expression of Lor, Krt10, and Flg, but not Krt5, was severely downregulated in the skin of Cflar E-KO ; Tnfrsf1a 2/2 mice compared with Tnfrsf1a 2/2 mice at P5 to P7 (Fig 5, C) . Together, expression of late, but not early, epidermal differentiation markers was downregulated in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice at both the mRNA and protein levels soon after birth.
Epidermis-specific Cflar-deficient mice on the Tnfrsf1a 1/2 background results in embryonic lethality A previous study has shown that Cflar E-KO mice on the Tnfrsf1a 1/1 background die in utero at E11 to E14. 26 However, the detailed characterization of mice has not been reported yet, prompting us to generate Cflar E-KO ;Tnfrsf1a 1/2 mice and investigate the cause of embryonic lethality in more detail. Consistent with a previous study, 26 we could not obtain viable Cflar E-KO ; Tnfrsf1a 1/2 mice after birth. Timed mating revealed that Cflar E-KO ;Tnfrsf1a 1/2 mice grew normally until E14.5 to E16.5; however, almost all Cflar E-KO ;Tnfrsf1a 1/2 mice died in utero before birth (see Table E3 in this article's Online Repository at www.jacionline.org). The skin of Cflar E-KO ;Tnfrsf1a 1/2 mice at E18.5 appeared to be rough and pale compared with that of Tnfrsf1a 1/2 mice (Fig 6, A) . Epidermal cells appeared to be normal at E14.5 (Fig 6, B) , whereas large numbers of epidermal cells died of apoptosis in Cflar E-KO ;Tnfrsf1a 1/2 mice at E18.5 (Fig 6, C and D) . Expression of Tnf was significantly increased in the skin of Cflar E-KO ;Tnfrsf1a 1/2 mice compared with Tnfrsf1a 1/2 mice at E18.5 (Fig 6, E) . Although numbers of Ki67 1 proliferating basal cells were regularly arranged in the epidermis of Tnfrsf1a 1/2 mice, those cells disappeared completely in the epidermis in Cflar E-KO ;Tnfrsf1a 1/2 mice (Fig  6, F) . Large numbers of Ki67 1 cells accumulated in the dermis, and suprabasal layers of Cflar E-KO ;Tnfrsf1a 1/2 mice appeared to be infiltrated monocytes and macrophages. Taken that deletion of Tnfrsf1a completely rescued embryonic lethality of Cflar E-KO mice (see Table E2 ) and expression of Tnf was increased in the skin of Cflar E-KO ;Tnfrsf1a 1/2 mice (Fig 6, E) , these results suggest that TNF-a-induced apoptosis is the primary cause of embryonic lethality of Cflar E-KO ;Tnfrsf1a 1/2 mice.
Epidermal differentiation is blocked in the epidermis in Cflar E-KO ;Tnfrsf1a 1/2 mice
We found that expression of Lor, but not Krt10 or Krt5, was diminished in the epidermis in Cflar E-KO ;Tnfrsf1a 1/2 mice compared with that in Tnfrsf1a 1/2 mice at E18.5 using immunohistochemistry and Western blotting (Fig 7, A and B) . On the other hand, consistent with a lack of processed Flg in the skin of (Fig 7, D) . Together, epidermal differentiation was blocked in the skin of Cflar E-KO ;Tnfrsf1a 1/2 mice along with cell death in utero.
Gene expression profile of epidermis-specific Cfardeficient mice
To investigate the mechanisms underlying blockade of epidermal differentiation in Cflar E-KO ;Tnfrsf1a 1/2 mice, we performed genome-wide transcriptomic analysis. To exclude the secondary effects of infection of the skin with commensal bacteria caused by impaired barrier function on gene expression, we compared the gene expression profiles of the skin between Cflar E-KO ;Tnfrsf1a 1/2 and Tnfrsf1a 1/2 mice at E18.5 (see Table E4 in this article's Online Repository at www.jacionline. org). We found that various cytokines and chemokines were upregulated in the skin of Cflar E-KO ;Tnfrsf1a 1/2 mice compared with control mice. Among them, we confirmed that expression of Il6, Il11, Il19, Il33, and Osm was significantly increased in the skin of Cflar E-KO ;Tnfrsf1a 1/2 mice using quantitative PCR (see Fig E3, A, in this article's Online Repository at www.jacionline.org). Although expression of these cytokines was comparable between Tnfrsf1a 2/2 and Cflar E-KO ;Tnfrsf1a 2/2 mice at P0, these cytokines, except for Il33, increased progressively in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7 (see Fig E3, B and C) .
IL-6 and, to a lesser extent, IL-17A downregulate expression of keratinocyte differentiation markers
Previous studies have shown that expression of the constitutively active mutant STAT3 in the epidermis results in the development of psoriasis-like skin disease. 40 Indeed, we found that STAT3 was phosphorylated in the skin of Cflar E-KO ; Tnfrsf1a 1/2 mice at E18. 5 and Cflar E-KO ;Tnfrsf1a 2/2 mice at J ALLERGY CLIN IMMUNOL VOLUME 143, NUMBER 1
FIG 7.
Epidermal differentiation is blocked in the skin of Cflar E-KO ;Tnfrsf1a 1/2 mice. A and C, Skin sections of mice at E18.5 were stained with the indicated antibodies (red or green; n 5 4 mice per each genotype). Nuclei were stained with 49-6-diamidino-2-phenylindole dihydrochloride (DAPI). Scale bars 5 100 mm. Asterisks indicate nonspecific staining. B and D, Extracts from the skin of mice at E18.5 were analyzed by using immunoblotting. Each number indicates an individual mouse. Results are representative of 2 independent experiments (n 5 4 mice per each genotype). Primary keratinocytes were stimulated with IL-6 (20 ng/mL), IL-24 (20 ng/mL), or IL-17A (20 ng/mL) for 10 minutes, and phosphorylation of STAT3 and IkBa was analyzed by using immunoblotting. C, IL-6 and, to a lesser extent, IL-17A downregulate mRNA expression of epidermal differentiation markers. Primary keratinocytes were cultured as in Fig 8, B , for 96 hours, and expression of indicated genes was analyzed as in Fig 8, A. Results are means 6 SDs of triplicate samples. D, IL-6 downregulates expression of Lor. Primary keratinocytes were treated as in Fig 8, C , and cell lysates were analyzed by using immunoblotting. E, Survival of Cflar E-KO ;Tnfrsf1a 2/2 mice treated with control IgG (dotted line, n 5 7) or anti-IL-6 antibody (thick line, n 5 11). Statistical significance was determined by using the log-rank test. *P < .05, **P < .01, and ***P < .001. ns, Not significant. All results are representative of 2 to 4 independent experiments.
P5 to P7, but not P0, using immunohistochemistry and Western blotting (see Fig E4 in this article's Online Repository at www. jacionline.org). Deletion of the receptor for IL-24 that activates STAT3 completely rescues the skin phenotypes of epidermisspecific Ikkb-deficient mice. 7 Although TNF-a, IL-6, IL-17A, and IL-22 are involved in the development of psoriasis, 12, 41 expression of Il22 was not increased in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice compared with Tnfrsf1a 2/2 mice at P5 to P7 (see Fig E3, C) . Therefore we tested whether treatment of primary keratinocytes with IL-6, IL-17A, or IL-24 blocked keratinocyte differentiation. We prepared primary keratinocytes from Tnfrsf1a 2/2 and Cflar E-KO ;Tnfrsf1a 2/2 mice at P0 and induced their differentiation. In contrast to previous studies, 42 at least under our experimental conditions, an increase in calcium concentrations in culture medium did not induce differentiation of primary keratinocytes (data not shown). However, primary keratinocytes underwent differentiation at 3 to 4 days after confluence based on upregulation of Lor, Flg, and Krt10, but not Krt5 (Fig 8,  A) . We found that IL-6, but not IL-24, induced phosphorylation of STAT3 in primary keratinocytes 10 minutes after stimulation, whereas IL-17A only slightly induced phosphorylation of IkBa (Fig 8, B) . Under these experimental conditions, IL-6 and, to a lesser extent, IL-17A significantly blocked upregulation of Lor, Flg, and Krt10, but not Krt5 (Fig 8, C) . Consistent with no effect of TNF-a on cell viability of keratinocytes from Cflar E-KO ; Tnfrsf1a 2/2 mice (Fig 2, B) , TNF-a did not block upregulation of differentiation markers of keratinocytes from either Tnfrsf1a 2/2 or Cflar E-KO ;Tnfrsf1a 2/2 mice (see Fig E5 in this article's Online Repository at www.jacionline.org). In contrast to dramatic amelioration of the skin phenotype of Ikkb-deficient mice on a Il24 receptor-deficient background, 7 IL-24 only weakly downregulated the expression of these differentiation markers. Thus it is reasonable to speculate that the primary target or targets of IL-24 are not keratinocytes but other cell types. We also confirmed that IL-6 treatment downregulated expression of Lor at protein levels along with phosphorylation of STAT3 at 96 hours after stimulation (Fig 8, D) .
To further extend our findings in vivo, we injected newborn Cflar E-KO ;Tnfrsf1a 2/2 mice with anti-IL-6 antibody from P3 and continued injection every other day until the pups died. Treatment of Cflar E-KO ;Tnfrsf1a 2/2 mice with anti-IL-6 antibody slightly prolonged their survival compared with those mice treated with control IgG (Fig 8, E) . Phosphorylation of STAT1, but not IkBa, was also induced in the skin of Cflar E-KO ; Tnfrsf1a 1/2 mice at E18. 5 and Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7 but not P0 (see Fig E6 in mice.
DISCUSSION
In the present study we have shown that Cflar E-KO mice died in utero and Cflar E-KO ;Tnfrsf1a 2/2 mice were born at the expected Mendelian ratio but still had severe dermatitis and succumbed soon after birth. Treatment of Cflar E-KO ;Tnfrsf1a 2/2 mice with neutralizing antibodies against FasL and TRAIL substantially prolonged their survival compared with that of control IgG-treated mice. Expression of inflammatory cytokines, such as IL-6, IL-17A, and IL-24, was increased in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7; conversely, expression of epidermal differentiation markers, including Lor, Flg, and Krt10, was downregulated. Treatment of primary keratinocytes with IL-6 and, to a lesser extent, IL-17A resulted in a decrease in expression of these epidermal differentiation markers. Together, cFLIP blocks TNFR1-dependent and TNFR1-independent apoptosis of keratinocytes, thereby preventing blockade of epidermal differentiation. Thus suppression of both TNFR1-dependent and TNFR1-independent cell death might be an alternative strategy to treat human skin diseases when treatment with anti-TNF-a antibody alone is not sufficient.
Deletion 33 Hence apoptotic keratinocytes can release chemokines that recruit inflammatory monocytes, which further exacerbated dermatitis.
Given that the effect of neutralizing antibodies against FasL and TRAIL on survival of Cflar E-KO ;Tnfrsf1a 2/2 mice was partial, other signaling pathways leading to cell death might also be involved in premature lethality and development of lethal dermatitis. Although TNF-a mediates cytotoxicity in certain cells through TNFR2, 35 TNF-a did not decrease cell viability or block upregulation of differentiation markers of keratinocytes from Cflar E-KO ;Tnfrsf1a 2/2 mice. Thus death ligands other than TNF-a, FasL, or TRAIL might also contribute to development of skin diseases. Accumulating studies have shown that keratinocytes undergo pyroptosis in response to bacterial infection. 37, 38 Indeed, expression of a component of the inflammasome, such as Nlrp3 and Il1b, was significantly increased in the skin of Cflar E-KO ;Tnfrsf1a 2/2 mice. Moreover, caspase 8, other than caspase 1 or caspase 11, might also be involved in activation of the inflammasome under certain conditions. 43 Taken that caspase 8 activation is easily induced under cFLIP-deficient conditions, pyroptotic cell death of keratinocytes might also contribute to lethal dermatitis. Further study will be required to address this issue.
Although we stained skin samples of patients with dermatitis with anti-CC3 antibody, we could not detect apoptotic cells in the skin of chronic atopic dermatitis or psoriasis lesions. One might surmise that the vicious cycle between inflammation and impaired skin barrier function might be caused by a yet unknown mechanism other than cell death of keratinocytes. In contrast, a previous study reported that T cell-dependent apoptosis is detected in acute lesions of eczematous dermatitis. 44 Taken that apoptotic cells are cleared rapidly by phagocytes in vivo, 45 we cannot formally exclude the possibility that small numbers of apoptotic keratinocytes per se might play a role, at least in part, in the development of atopic dermatitis and psoriasis. Further study will be required to address this issue.
The phenotype of Cflar E-KO ;Tnfrsf1a 2/2 mice is reminiscent of those of epidermis-specific NF-kB activation-deficient mice, in which enhanced cell death appears to block epidermal differentiation. [5] [6] [7] [8] [9] [10] [11] Taken that Tnfrsf1a deficiency significantly prolongs survival of epidermis-specific NF-kB activation-deficient mice, 5-11 the phenotype of Cflar deficiency in the epidermis was very severe compared with that in epidermis-specific NFkB activation-deficient mice. We found that expression of inflammatory cytokines was increased, and conversely, expression of Lor, Flg, and Krt10 was severely downregulated in the epidermis of Cflar E-KO ;Tnfrsf1a 2/2 mice at P5 to P7. However, expression of inflammatory cytokines and epidermal differentiation markers was not different between Tnfrsf1a 2/2 and Cflar E-KO ;Tnfrsf1a 2/2 mice at birth. Together, these results suggest that commensal bacterial infection triggers FasL-or TRAIL-induced cell death and/or pyroptosis that subsequently induce inflammatory cytokine production. Produced inflammatory cytokines might impair normal skin barrier function, resulting in further exacerbation of commensal bacterial infection. Treatment of primary keratinocytes from either type of genotyped mouse with IL-6 dramatically downregulated expression of epidermal differentiation markers, such as Lor and Flg. However, administration of neutralizing antibody against IL-6 only weakly prolonged survival of Cflar E-KO ; Tnfrsf1a 2/2 mice. This suggests that cytokines other than IL-6, such as IL-17A, IL-24, IL-11, IFN-g, or oncostatin M can also contribute to the skin phenotype of Cflar E-KO ;Tnfrsf1a 2/2 mice. Alternatively, taken that inflammatory cytokine production and subsequent blockade of epidermal differentiation are secondary events of cell death, suppression of cell death but not prevention of cytokine-dependent blockade of epidermal differentiation might be essential for preventing lethal dermatitis.
It would be intriguing to investigate the mechanism by which IL-6 downregulates expression of Lor, Flg, and Krt10. Epidermisspecific Stat3-deficient mice do not show a defect in skin development but do show an impaired wound healing response. 30 Conversely, expression of constitutively active mutant STAT3 in the skin results in development of psoriasis-like dermatitis in mice. 40 Moreover, a STAT3 inhibitor ameliorates skin xenografts from patients with psoriasis and attenuates blockade of epidermal differentiation. 40, 46 Together, these results suggest that STAT3-dependent signals promote proliferation of keratinocytes but downregulate expression of Lor, Flg, and Krt10.
Although the mechanisms underlying STAT3-dependent downregulation of these genes remain unclear, expression of these genes might be regulated by microRNA. Indeed, STAT3 induces expression of miR-21, which plays a causal role in the development of psoriasis through reduction of epidermal tissue inhibitor of matrix metalloproteinase 3 expression. 47 Thus it would be intriguing to test whether microRNAs induced by STAT3 promote degradation of mRNAs of Lor, Flg, and Krt10. Alternatively, STAT3 suppresses expression of Lor, Flg, and Krt10 through epigenetic regulation, including histone modification or promoter methylation. Taken that STAT3 inhibitors can affect broad biological effects, understanding of the mechanisms underlying STAT3-dependent suppression of epidermal differentiation might be crucial to develop a novel strategy to treat human skin diseases, such as psoriasis. and Cflar E-KO ;Tnfrsf1a 2/2 mice. mRNA expression of indicated genes in the skin of mice at E18.5 (A), P0 (B), and P5 to P7 (C) was determined by using quantitative PCR. Results are means 6 SEMs (n 5 4-10 mice per each genotype). *P < .05, **P < .01, ***P < .001. ND, Not detected; ns, not significant.
FIG E4.
STAT3 phosphorylation is increased in the skin of Cflar E-KO ; Tnfrsf1a 2/2 mice. A, Skin sections of mice at E18.5, P0, and P5 to P7 were stained with anti-phospho-STAT3 antibody (green; n 5 6 mice per each genotype). Nuclei were stained with 49-6-diamidino-2-phenylindole dihydrochloride (DAPI). Scale bars 5 100 mm. B, Extracts from the skin of mice as described in Fig E4, 
